Proposal of a flow chart for thrombosis-free oral contraceptive therapy

Clinical and Applied Thrombosis/Hemostasis

Volumn 9, Issue 1, 2003, Pages 33-37

  Girolami, Antonio ^a   Spiezia, Luca ^a   Vianello, Fabrizio ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

Author keywords

Oral contraceptive therapy; Thrombosis; Venous thromboembolism

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ALGORITHM; ARTICLE; CONGENITAL DISORDER; DRUG CONTRAINDICATION; FAMILY HISTORY; HIGH RISK POPULATION; HUMAN; ORAL CONTRACEPTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; THROMBOEMBOLISM; THROMBOSIS; VEIN THROMBOSIS;

EID: 0037222639     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/107602960300900104     Document Type: Article

References (25)

1. Vessey M, Mant D, Smith A, et al. Oral contraceptives and venous thromboembolism: Finding in a large prospective study. Br Med J 1986;292:526.
2. World Health Organization collaborative study of cardiovascular disease and steroid hormone contraception, venous thromboembolic disease and combined oral contraceptives: Results of international multicentre case-control study. Lancet 1995;346:1575.
3. Vandenbroucke JP, Rosing J, Bloemenkamp KW, et al. Oral contraceptives and the risk of venous thrombosis. N Engl J Med 2001;344:1527.
4. Walker AM. Newer oral contraceptives and the risk of venous thromboembolism. Contraception 1998;57:169.
5. Girolami A, Simioni P, Zanardi S. The role of drugs, particularly oral contraceptives in triggering thrombosis in congenital defects of coagulation inhibitors: A study of six patients. Blood Coagul Fibrinolysis 1991;2:673.
6. Girolami A, Stevanato F, Lazzaro AR. Bilateral ileofemoral thrombophlebitis after ten contraceptive pills in a 25-year-old woman with antithrombin III deficiency. Acta Haematol 1988;79:118.
7. Girolami A, Simioni P, Sartori MT, et al. Oral contraceptives caused thrombosis in a monoovular twin protein C deficiency, while the other, without medication, remained asymptomatic. Blood Coagul Fibrinolysis 1992;3:119.
8. Girolami A, Tormene D, Vianello F. Prothrombotic activity of oral contraceptives in patients with congenital thrombophilia varies with the defect. Clin Appl Thromb Hemost 2001;7:76.
9. Girolami A, Simioni P, Tormene D. APC resistance, oral contraceptive therapy and deep vein thrombosis: Settled and unsettled problems. Haematologica 2000;85:225.
10. Girolami A, Spiezia L, Girolami B, et al. Tentative guidelines and practical suggestions in order to avoid venous thromboembolism during oral contraceptive therapy. Clin Appl Thromb Hemost 2002;8:97.
11. Committee on Safety of Medicine: Combined oral contraceptives containing desogestrel or gestodene and the risk of venous thromboembolism. Curr Probl Pharmachovig 1999;25:12.
12. World Health Organization collaborative study of cardiovascular disease and steroid hormone contraception. Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. Lancet 1995;346:1582.
13. Helmerhorst FM, Bloemenkamp KW, Rosendaal FR, et al. Oral contraceptives and thrombotic disease: Risk of venous thromboembolism. Thromb Haemost 1997;78:327.
14. Jick H, Jick SS, Gurewich V, et al. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components. Lancet 1995;346:1589.
15. Farmer RD, Williams TJ, Simpson EL, et al. Effect of 1995 pill scare on rates of venous thromboembolism among women taking combined oral contraceptives: Analysis of general practice research database. BMJ 2000;321:477.
16. O'Brien PA. The third generation oral contraceptive controversy. The evidence shows they are less safe than second generation pills. BMJ 1999;319:795.
17. Spitzer WO, Lewis MA, Heinemann LA, et al. Third generation oral contraceptives and risk of venous thromboembolic disorders: An international case-control study. Transnational research group on oral contraceptives and the health of young women. BMJ 1996;312:83.
18. Skegg DC. Third generation oral contraceptives. BMJ 2000;321:190.
19. Girolami A, Simioni P, Girolami B, et al. Homozygous patients with APC resistance may remain paucisymptomatic or asymptomatic during oral contraception. Blood Coagul Fibrinolysis 1996;7:590.
20. Girolami A, Tormene D, Simioni P, et al. Long-term use of oral contraceptive therapy in women with the prothrombin 20210 g-a polymorphism without thrombotic complications: A study of 13 women (12 heterozygotes and 1 homozygote). Thromb Res 2001;102:205.
21. Cosmi B, Legnani C, Bernardi F, et al. Value of family history in identifying women at risk of venous thromboembolism during oral contraception: Observational study. BMJ 2001;322:1024.
22. Lapostolle F, Surget V, Borron SW, et al. Severe pulmonary embolism associated with air travel. N Engl J Med 2001;345:779.
23. Prandoni P, Lensing AW, Cogo A, et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 1996;125:1.
24. Carter CJ. The natural history and epidemiology of venous thrombosis. Prog Cardiovasc Dis 1994;36:423.
25. Hannaford PC, Owen-Smith V. Using epidemiological data to guide clinical practice: Review of studies on cardiovascular disease and use of combined oral contraceptives. BMJ 1998;316:984.